«The option of rapidly creating a completely
synthetic formulation that can be effective as a vaccine is an important addition to currently available vaccine strategies,» says Hidde Ploegh, an MIT professor of
biology, a member of the Whitehead Institute, and an author of the paper, who
added that it will be important to assess safety and cost.